Cancer incidence in the United Kingdom: projections to the year 2030.

The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer (2015) 2.63

Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer (2012) 2.24

Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer (2015) 1.60

Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010. BMC Med (2015) 1.41

1. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 1.26

Comment on 'cancer incidence in the United Kingdom: projections to the year 2030'. Br J Cancer (2013) 1.12

Industrializing skin cancer care: better and cheaper? J R Soc Med (2012) 1.09

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients. Br J Cancer (2012) 0.95

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study. PLoS Med (2016) 0.95

Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020. BMC Cancer (2013) 0.88

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience (2016) 0.88

Minimally invasive surgery as a treatment option for gastric cancer in the elderly: comparison with open surgery for patients 80 years and older. Surg Endosc (2014) 0.88

Planning for the future: cancer incidence projections in Switzerland up to 2019. BMC Public Health (2014) 0.86

Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS One (2013) 0.85

Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis (2014) 0.85

Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England. Br J Cancer (2013) 0.85

The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiol Biomarkers Prev (2015) 0.84

Cancer Mortality Projections in Korea up to 2032. J Korean Med Sci (2016) 0.84

Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health (2015) 0.83

Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden. Lung Cancer Int (2015) 0.82

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study. Lancet Oncol (2016) 0.82

Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age (Dordr) (2014) 0.81

The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer. Support Care Cancer (2013) 0.79

Trends in UK regional cancer mortality 1991-2007. Br J Cancer (2016) 0.78

Future of palliative medicine. Indian J Palliat Care (2015) 0.77

Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme. Br J Cancer (2015) 0.77

Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain. BMC Cancer (2014) 0.76

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends. BMJ Open (2016) 0.76

Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients. Oncotarget (2016) 0.75

Complexities of abdominoperineal surgery: synchronous resection of an ano-rectal adenocarcinoma and pelvic schwannoma. J Surg Case Rep (2014) 0.75

The future excess fraction model for calculating burden of disease. BMC Public Health (2016) 0.75

Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study. BMJ Open (2016) 0.75

The anatomy of clinical decision-making in multidisciplinary cancer meetings: A cross-sectional observational study of teams in a natural context. Medicine (Baltimore) (2016) 0.75

Reply to 'comment on cancer incidence in the United Kingdom: projections to the year 2030'. Br J Cancer (2013) 0.75

Outcome of Skeletal Reconstructive Surgery for Metastatic Bone Tumours in the Femur. Malays Orthop J (2017) 0.75

Trends in Gastrointestinal cancer incidence in Iran, 2001-2010, with joinpoint analysis. Epidemiol Health (2016) 0.75

Cancer incidence and mortality projections in the UK until 2035. Br J Cancer (2016) 0.75

Forecasting Cause-Specific Mortality in Korea up to Year 2032. J Korean Med Sci (2016) 0.75

Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan. PLoS One (2016) 0.75

The epidemiology and risk factors for renal cancer. Curr Urol (2013) 0.75

Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained? Breast Cancer (Dove Med Press) (2017) 0.75

Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries. Eur J Clin Nutr (2016) 0.75

The proliferation of multidisciplinary team meetings (MDTMs): how can radiology departments continue to support them all? Eur Radiol (2015) 0.75

Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence. Pharmacoeconomics (2017) 0.75

Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden. Support Care Cancer (2016) 0.75

Feasibility of laparoscopic gastrectomy for elderly gastric cancer patients: meta-analysis of non-randomized controlled studies. Oncotarget (2017) 0.75

Predicting the future burden of cancer. Nat Rev Cancer (2006) 6.10

Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50

Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev (2002) 3.40

Age-period-cohort models for the Lexis diagram. Stat Med (2007) 2.65

Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med (2003) 2.27

The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer (2007) 1.79

Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52

Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer (2009) 1.45

Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int (2000) 1.27

Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen (2008) 1.25

A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015. CA Cancer J Clin (2007) 1.12

Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61

Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11

Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ (1991) 5.44

Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39

Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79

Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35

Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32

Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13

Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99

A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98

The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83

Cervical sampling devices. BMJ (1996) 2.74

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer (1997) 2.65

Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol (2015) 2.61

Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer (1993) 2.58

Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52

Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36

Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35

A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32

Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30

Trends in cervical cancer mortality. Lancet (1991) 2.28

The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18

Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14

Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen (2003) 2.07

An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Community Health (1986) 2.02

Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health (2001) 2.01

How successful is screening for congenital disease of the hip? Am J Public Health (1981) 1.97

Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95

The management of hypertension--a study of records in general practice. J R Coll Gen Pract (1979) 1.95

Effectiveness of neonatal screening for congenital dislocation of the hip. Lancet (1978) 1.92

Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull (1996) 1.87

Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989. Cancer (1995) 1.86

An overview of cancer survival in developing countries. IARC Sci Publ (1998) 1.84

Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet (1996) 1.81

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79

International variations in the incidence of neuroblastoma. Int J Cancer (1992) 1.77

Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev (2000) 1.76

APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71

Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer (2000) 1.70

Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health (2004) 1.70

Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol (2005) 1.64

Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS (1999) 1.61

International variations in the incidence of childhood renal tumours. Br J Cancer (1990) 1.61

Cancer survival in Kampala, Uganda. Br J Cancer (2005) 1.58

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer (1998) 1.56

Cancer incidence in Karachi, Pakistan: first results from Karachi Cancer Registry. Int J Cancer (2000) 1.55

Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer (2006) 1.54

Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J Clin Pathol (1999) 1.54

The demonstration and function of antibodies in the gastrointestinal tract. Gut (1972) 1.53

Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer (1998) 1.52

Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer (2008) 1.52

Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol (2004) 1.51

Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer (1990) 1.47

Sampling methods for cervical smears. Acta Cytol (1992) 1.45

Cervical cytology screening in two Yorkshire areas: pattern of service. Public Health (1981) 1.45

The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen (2012) 1.44

Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer (2000) 1.44

Dietary and endogenous cholesterol and human cancer. Epidemiol Rev (1984) 1.44

PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci (2001) 1.42

Cancer in Mali, 1987-1988. Int J Cancer (1990) 1.41

Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer (1989) 1.40

Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. Eur J Cancer (2004) 1.40

Lung cancer screening. Chest (1994) 1.40

Cancer in the Gambia: 1988-97. Br J Cancer (2001) 1.38

Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol (1992) 1.37

Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst (2000) 1.34

Women's understanding of a "normal smear test result": experimental questionnaire based study. BMJ (2001) 1.33

Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years. Br J Cancer (2013) 1.33

Could HPV testing become the sole primary cervical screening test? J Med Screen (2002) 1.31

Cancer and HIV infection in Rwanda. Lancet (1995) 1.31

Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer (2013) 1.29

The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol (2002) 1.29

Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev (2005) 1.29

Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995-1997. Cancer (2000) 1.25

The management of hypertension--a survey of opinions among general practitioners. J R Coll Gen Pract (1979) 1.25

13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer (2011) 1.25

Predicting the impact of the screening programme for colorectal cancer in the UK. J Med Screen (2008) 1.25

Small-intestinal immunoglobulin levels in dermatitis herpetiformis. Lancet (1972) 1.24

Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex (2003) 1.24

Cervical cytology screening in two Yorkshire areas: results of testing. Public Health (1982) 1.22

Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer (2004) 1.22

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21

Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer (2004) 1.20

Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20

Log-linear models for cancer risk among migrants. Int J Epidemiol (1990) 1.19

Risk factors for invasive cervix cancer in young women. Eur J Cancer (1996) 1.19

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer (2010) 1.18

Cancer in Rwanda. Int J Cancer (1996) 1.18

[Time trends, estimates and projects for breast cancer incidence and mortality in China]. Zhonghua Zhong Liu Za Zhi (2006) 1.17

Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer (2001) 1.16

The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer (1998) 1.15

Cancer in developing countries. CA Cancer J Clin (1994) 1.14

Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer (1997) 1.14

A computer simulation model for the practical planning of cervical cancer screening programmes. Br J Cancer (1985) 1.13

International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol (1994) 1.12

Intestinal bacterial flora and bile salt studies in hypogammaglobulinaemia. Gut (1972) 1.10

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer (2010) 1.09